ArticleJournal of ophthalmology2026
Glycosylation-Associated Macrophage Signatures Define a Diagnostic Model for Diabetic Retinopathy via Single-Cell Analysis.
Article in Journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Glycosylation-Associated Macrophage Signatures Define a Diagnostic Model for Diabetic Retinopathy via Single-Cell Analysis.Journal of ophthalmology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Diabetic retinopathy (DR) remains a leading cause of vision loss, with macrophages and glycosylation dysregulation implicated in DR pathogenesis. However, the potential as diagnostic biomarkers has been rarely investigated. Methods: We integrated single-cell RNA sequencing (scRNA-seq) datasets to profile DR cell landscapes. The immune cell heterogeneity was dissected, and glycosylation-related transcriptional programs were delineated in DR. Machine learning-based diagnostic modeling was also conducted to identify macrophage differentiation-related glycosylation genes (MDRGGs). Results: Macrophages exhibited elevated abundance in proliferative DR and showed intense interactions with other monocytes. Endothelial cells were subdivided into four subtypes, with Endo_KCNQ3 representing a dominant proliferative and highly glycosylated phenotype. Monocytes were clustered into three subtypes; Mono_RGS1 emerged as a transitional phenotype in the monocyte-to-macrophage trajectory. Macro_MIR181A1HG was identified as a proliferative and glycosylation-active macrophage subset. A total of 100 MDRGGs were identified. Among them, seven hub genes (AKAP13, SRGAP2, AFF1, ARHGAP24, RNF149, PTK2B, ATP1B3) were incorporated into a diagnostic model. The model achieved high predictive accuracy in both training and external validation cohorts (AUC > 0.85) and was further validated via nomogram and decision curve analyses. Conclusion: Glycosylation is closely associated with macrophage heterogeneity in DR. A seven-gene MDRGG-based diagnostic model demonstrated robust diagnostic performance in DR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.